Cargando…

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis

Introduction Rheumatoid arthritis is a chronic, inflammatory, and multisystem disease, which, along with the joints, can involve the cardiovascular system. The treatment of rheumatoid arthritis or rheumatoid arthritis itself can lead to atherosclerosis, which is considered one of the major causes by...

Descripción completa

Detalles Bibliográficos
Autores principales: Mal, Kheraj, Kumar, Ratan, Mansoor, Farah, Kaur, Navneet, Kumar, Anil, Memon, Sidra, Rizwan, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823064/
https://www.ncbi.nlm.nih.gov/pubmed/33505813
http://dx.doi.org/10.7759/cureus.12246
_version_ 1783639756188418048
author Mal, Kheraj
Kumar, Ratan
Mansoor, Farah
Kaur, Navneet
Kumar, Anil
Memon, Sidra
Rizwan, Amber
author_facet Mal, Kheraj
Kumar, Ratan
Mansoor, Farah
Kaur, Navneet
Kumar, Anil
Memon, Sidra
Rizwan, Amber
author_sort Mal, Kheraj
collection PubMed
description Introduction Rheumatoid arthritis is a chronic, inflammatory, and multisystem disease, which, along with the joints, can involve the cardiovascular system. The treatment of rheumatoid arthritis or rheumatoid arthritis itself can lead to atherosclerosis, which is considered one of the major causes by which it can affect the cardiovascular system. In this study, we will assess the risk of cardiovascular events in patients with rheumatoid arthritis as compared to the general population. Method This case-control study was conducted from January 2018 to November 2018. Two-hundred twenty-two (222) patients with diagnosed rheumatoid arthritis were included as cases in the study. Two-hundred eleven (211) patients were included in the study as the control group (patients without rheumatoid arthritis). All the data were recorded in a self-structured questionnaire. Result Participants with rheumatoid arthritis also showed an increased risk of myocardial infarction (MI) by an odds ratio of 2.50 (95% CI; 0.77-8.14). There was also an increased risk of cardiovascular death in participants with rheumatoid arthritis by an odds ratio of 1.99 (0.58-6.71). Conclusion The study suggests that rheumatoid arthritis along with joint inflammation can also affect the cardiovascular system. Hence, a multidisciplinary team of rheumatologists and cardiologists should manage patients suffering from rheumatoid arthritis, which will improve morbidity and mortality in such patients.
format Online
Article
Text
id pubmed-7823064
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-78230642021-01-26 Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Mal, Kheraj Kumar, Ratan Mansoor, Farah Kaur, Navneet Kumar, Anil Memon, Sidra Rizwan, Amber Cureus Cardiology Introduction Rheumatoid arthritis is a chronic, inflammatory, and multisystem disease, which, along with the joints, can involve the cardiovascular system. The treatment of rheumatoid arthritis or rheumatoid arthritis itself can lead to atherosclerosis, which is considered one of the major causes by which it can affect the cardiovascular system. In this study, we will assess the risk of cardiovascular events in patients with rheumatoid arthritis as compared to the general population. Method This case-control study was conducted from January 2018 to November 2018. Two-hundred twenty-two (222) patients with diagnosed rheumatoid arthritis were included as cases in the study. Two-hundred eleven (211) patients were included in the study as the control group (patients without rheumatoid arthritis). All the data were recorded in a self-structured questionnaire. Result Participants with rheumatoid arthritis also showed an increased risk of myocardial infarction (MI) by an odds ratio of 2.50 (95% CI; 0.77-8.14). There was also an increased risk of cardiovascular death in participants with rheumatoid arthritis by an odds ratio of 1.99 (0.58-6.71). Conclusion The study suggests that rheumatoid arthritis along with joint inflammation can also affect the cardiovascular system. Hence, a multidisciplinary team of rheumatologists and cardiologists should manage patients suffering from rheumatoid arthritis, which will improve morbidity and mortality in such patients. Cureus 2020-12-23 /pmc/articles/PMC7823064/ /pubmed/33505813 http://dx.doi.org/10.7759/cureus.12246 Text en Copyright © 2020, Mal et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Mal, Kheraj
Kumar, Ratan
Mansoor, Farah
Kaur, Navneet
Kumar, Anil
Memon, Sidra
Rizwan, Amber
Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
title Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
title_full Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
title_fullStr Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
title_full_unstemmed Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
title_short Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
title_sort risk of major adverse cardiovascular events in patients with rheumatoid arthritis
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823064/
https://www.ncbi.nlm.nih.gov/pubmed/33505813
http://dx.doi.org/10.7759/cureus.12246
work_keys_str_mv AT malkheraj riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis
AT kumarratan riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis
AT mansoorfarah riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis
AT kaurnavneet riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis
AT kumaranil riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis
AT memonsidra riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis
AT rizwanamber riskofmajoradversecardiovasculareventsinpatientswithrheumatoidarthritis